Substance / Medication

Human insulin

Overview

Active Ingredient
insulin, regular, human
RxNorm CUI
253182

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

2 trials linked to this intervention

2
Total Trials
0
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Thermal stability and storage of human insulin.
Richter Bernd, Bongaerts Brenda, Metzendorf Maria-Inti · Cochrane Database Syst Rev · 2023
PMID: 37930742Meta-AnalysisFull text (PMC)
Safety of intranasal human insulin: A review.
Schmid Vera, Kullmann Stephanie, Gfrörer Wieland et al. · Diabetes Obes Metab · 2018
PMID: 29508509Meta-Analysis
Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.
Fullerton Birgit, Siebenhofer Andrea, Jeitler Klaus et al. · Cochrane Database Syst Rev · 2018
PMID: 30556900Meta-AnalysisFull text (PMC)
Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
Fullerton Birgit, Siebenhofer Andrea, Jeitler Klaus et al. · Cochrane Database Syst Rev · 2016
PMID: 27362975Meta-AnalysisFull text (PMC)
Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis.
Wojciechowski Piotr, Niemczyk-Szechowska Patrycja, Olewińska Elżbieta et al. · Pol Arch Med Wewn · 2015
PMID: 25644227Meta-Analysis
Meta-analysis of insulin aspart versus regular human insulin used in a basal-bolus regimen for the treatment of diabetes mellitus.
Heller Simon, Bode Bruce, Kozlovski Plamen et al. · J Diabetes · 2013
PMID: 23586846Meta-AnalysisFull text (PMC)
Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease.
Beauverd Michel, Mitchell J D, Wokke John H J et al. · Cochrane Database Syst Rev · 2012
PMID: 23152212Meta-AnalysisFull text (PMC)
Are analogue insulins superior to human insulin in clinical practice?
Freeman Jeffrey S · Curr Diab Rep · 2010
PMID: 20425580Meta-Analysis
Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis.
Mannucci E, Monami M, Marchionni N · Diabetes Obes Metab · 2009
PMID: 18671795Meta-Analysis
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.
Monami Matteo, Marchionni Niccolò, Mannucci Edoardo · Diabetes Res Clin Pract · 2008
PMID: 18495286Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Human insulin (substance)
SNOMED CT
96367001
UMLS CUI
C0795635
RxNorm CUI
253182

Clinical Data

This intervention maps to 14 entities in the Healos knowledge graph.

5
Conditions
4
Biomarkers
3
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.